# Findings Summary

## Overview
This document provides an example of how flagged records from the project may be summarized after rule-based prescription data quality checks.

The purpose of the findings summary is to support structured review by grouping issues into practical categories:

- administrative / reimbursement-related
- documentation-quality
- safety-sensitive medication review flags

This summary does **not** make clinical decisions. It highlights records that may require clarification, documentation review, or closer pharmacist-facing evaluation.

---

## Example Findings

### 1. High Risk — Quantity vs Duration/Frequency Mismatch
**Prescription ID:** RX011  
**Medication:** Glucophage / Metformin  
**Issue:** Quantity dispensed does not plausibly match the documented frequency and duration.  
**Why it was flagged:** The record shows a chronic prescription with twice-daily use over 30 days, but the quantity dispensed appears lower than expected for that dosing pattern.  
**Category:** Safety-sensitive medication review flag

---

### 2. High Risk — Repeat Prescription Issued Too Early
**Prescription IDs:** RX005 and RX013  
**Medication:** Glucophage / Metformin  
**Issue:** The same patient received the same active ingredient again within a shorter interval than expected based on the refill window.  
**Why it was flagged:** This pattern may suggest duplicate supply, refill timing inconsistency, or a need for closer review of dispensing continuity.  
**Category:** Safety-sensitive medication review flag / administrative concern

---

### 3. Medium Risk — Diagnosis Code / Diagnosis Text Mismatch
**Prescription ID:** RX010  
**Medication:** Nexium / Esomeprazole  
**Issue:** Diagnosis code and diagnosis text do not appear aligned with the medication context.  
**Why it was flagged:** The coded and free-text diagnosis fields suggest a documentation inconsistency that may affect justification clarity or reimbursement review.  
**Category:** Administrative / reimbursement-related

---

### 4. Medium Risk — Missing or Vague Physician Comment
**Prescription ID:** RX004  
**Medication:** Nexium / Esomeprazole  
**Issue:** Physician comment is blank in a repeat prescription record.  
**Why it was flagged:** While not automatically unsafe, incomplete comments reduce traceability and weaken structured review of continuity or prescribing intent.  
**Category:** Documentation-quality issue

---

### 5. Medium Risk — Unexpected Therapy Switch Without Explanatory Note
**Prescription IDs:** RX007 and RX015  
**Medication Context:** Olmesartan to Losartan  
**Issue:** The same patient appears to move between chronic medications in the same therapeutic area without a meaningful explanatory note.  
**Why it was flagged:** This does not imply inappropriate treatment, but it does represent a therapy continuity signal that may require clarification.  
**Category:** Safety-sensitive medication review flag

---

### 6. Low Risk — Inconsistent Frequency Notation
**Prescription IDs:** RX006 and RX009  
**Medication Context:** Rosuvastatin / Prednisolone  
**Issue:** Frequency is recorded using inconsistent notation formats such as `1x/day` and `BID`.  
**Why it was flagged:** This reduces documentation consistency and makes structured review more difficult, even when the intended meaning may be understandable.  
**Category:** Documentation-quality issue

---

### 7. Low Risk — Dispense Date Earlier Than Issue Date
**Prescription ID:** RX003  
**Medication:** Deltacortril / Prednisolone  
**Issue:** Dispense date occurs before issue date.  
**Why it was flagged:** This is a basic chronological inconsistency and usually suggests a record-quality or data-entry problem.  
**Category:** Documentation-quality issue

---

## Summary by Risk Level

### High Risk
- Quantity vs duration/frequency mismatch
- Repeat prescription issued too early
- Same active ingredient appearing again too soon
- Therapy continuity concerns without explanatory note

### Medium Risk
- Diagnosis code / diagnosis text mismatch
- Missing reimbursement-related fields
- Missing or vague physician comments
- Duplicate patient-drug patterns requiring clarification

### Low Risk
- Inconsistent dosage unit formatting
- Inconsistent frequency notation
- Date-order inconsistencies
- Missing non-critical structured fields

---

## Practical Interpretation
In a real workflow, findings like these would not automatically lead to rejection or clinical intervention. Instead, they would serve as structured review signals that may prompt:

- clarification with the prescriber
- review of dispensing history
- closer examination of documentation completeness
- verification of reimbursement-related fields
- confirmation of continuity in repeat or chronic therapy

---

## What This Findings Summary Is Intended to Show
This example is meant to demonstrate:

- healthcare-informed data quality awareness
- structured QA and review thinking
- practical classification of flagged records
- a moderate, documentation-focused approach to prescription-level validation

It is not intended to simulate a real pharmacy system or replace pharmacist or physician judgment.
